Ramona Lloyd, Ph.D. is Vice President, Regulatory Affairs and Quality at OptiNose. In this role, Dr. Lloyd is responsible for regulatory strategy and quality in support of development and commercialization activities. A regulatory professional for more than 20 years, Dr. Lloyd has led or participated in the submission of numerous global investigational applications and successful marketing applications for small molecules, biologics and devices across multiple therapeutic areas. Prior to joining OptiNose, she served as both a consultant to the pharmaceutical industry and as an executive with Sanofi-Aventis, Bristol Myers-Squibb, and Johnson and Johnson. She acted as Sr. Vice President of Regulatory Affairs and Safety for ImClone Systems and has served as Vice President of Regulatory Affairs and Quality for public and private biotechs, leading global regulatory strategy, regulatory submissions through product approval and key meetings with global regulatory authorities. Dr. Lloyd earned a doctorate in Molecular Genetics and Microbiology from Rutgers University – Robert Wood Johnson Medical School, and was a researcher at the Center for Advanced Biotechnology and Medicine. She earned the professional credential in regulation of healthcare products, Regulatory Affairs Certified (RAC).

marketing applications for small molecules, biologics and devices across multiple therapeutic areas,consultant,Molecular Genetics and Microbiology ,regulation of healthcare products